Zobrazeno 1 - 10
of 17
pro vyhledávání: '"P H, Nissen"'
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 18-25 (2023)
Abstract When screening for α‐thalassemia in children, adult cut‐offs for mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) are generally applied to guide genetic evaluation. However, the normal ranges for MCV and MCH are lower
Externí odkaz:
https://doaj.org/article/bf69938d5a6a443c8162db36f85420e0
Autor:
Jenny Q. D. Tran, Oliver H. Pedersen, Mads L. Larsen, Erik L. Grove, Steen D. Kristensen, Anne-Mette Hvas, Peter H. Nissen
Publikováno v:
Platelets, Vol 31, Iss 3, Pp 365-372 (2020)
Essential thrombocythemia (ET) is characterized by persistently elevated platelet counts and an increased risk of thromboembolic events. Dysregulated expression of small noncoding microRNAs (miRNAs) have been shown in ET and may influence platelet ma
Externí odkaz:
https://doaj.org/article/3a2b2980b5b144c799395541060095ba
Publikováno v:
Platelets, Vol 31, Iss 2, Pp 215-220 (2020)
Point of care testing of residual effect of antiplatelet therapy in trauma patients or during major surgery may result in improved clinical management of significant bleeding. We included 121 healthy individuals (57 females and 64 males, aged 22–65
Externí odkaz:
https://doaj.org/article/d35abaac88fa46ff8cff703696a01bc9
Autor:
Pernille L. Kjeldsen, Peter Parbo, Kim V. Hansen, Joel F.A. Aanerud, Rola Ismail, Peter H. Nissen, Rikke B. Dalby, Malene F. Damholdt, Per Borghammer, David J. Brooks
Publikováno v:
Aging Brain, Vol 2, Iss , Pp 100048- (2022)
Introduction: The typical spatial pattern of amyloid-β (Aβ) in diagnosed Alzheimer’s disease (AD) is that of a symmetrical hemispheric distribution. However, Aβ may be asymmetrically distributed in early stages of AD. Aβ distribution on PET has
Externí odkaz:
https://doaj.org/article/d4f233cd10d145528054e34755010fb9
Autor:
Oliver Buchhave Pedersen, Leonardo Pasalic, Erik Lerkevang Grove, Steen Dalby Kristensen, Anne-Mette Hvas, Peter H. Nissen
Publikováno v:
Methods and Protocols, Vol 6, Iss 1, p 8 (2023)
Newly produced immature platelets are larger, contain higher amounts of residual RNA, and are more reactive than mature platelets. Flow cytometry using the SYTO-13 dye is a method for the subdivision of immature platelets from mature platelets based
Externí odkaz:
https://doaj.org/article/bec3d7b5969345e7ba850cb9e7d629df
Publikováno v:
TH Open, Vol 05, Iss 04, Pp e479-e488 (2021)
Protein S (PS) deficiency is a risk factor for venous thromboembolism (VTE) and can be caused by variants of the gene encoding PS (PROS1). This study aimed to evaluate the clinical value of molecular analysis of the PROS1 gene in PS-deficient partici
Externí odkaz:
https://doaj.org/article/381219e7f3b04e4fa3e1d099359ae01c
Publikováno v:
Platelets, Vol 29, Iss 4, Pp 421-424 (2018)
Pneumatic tube is an attractive way to transport blood samples from the emergency department to the central laboratory facility. We aimed to investigate the impact of pneumatic tube transportation on blood samples for analysis of whole blood coagulat
Externí odkaz:
https://doaj.org/article/13cbb6e9e15b48dfa01341955c7251fd
Publikováno v:
Platelets, Vol 29, Iss 2, Pp 199-202 (2018)
Flow cytometry is an increasingly used method for platelet function analysis because it has some important advantages compared with other platelet function tests. Flow cytometric platelet function analyses only require a small sample volume (3.5 mL);
Externí odkaz:
https://doaj.org/article/a8efa4e0d05045d19c0ed553438654d2
Publikováno v:
Frontiers in Endocrinology, Vol 8 (2017)
Externí odkaz:
https://doaj.org/article/e924bf57fd1b469aa6c456382436b272
Publikováno v:
Nissen, T P H, Vorum, H & Aasbjerg, K 2021, ' Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema ', Current Drug Safety, vol. 16, no. 1, pp. 17-31 . https://doi.org/10.2174/1574886315666200902154322
Nissen, T P H, Vorum, H & Aasbjerg, K 2021, ' Biologic therapy and treatment options in diabetic retinopathy with diabetic macular edema ', Current Drug Safety, vol. 16, no. 1, pp. 17-31 . https://doi.org/10.2174/1574886315666200902154322
Nissen, T P H, Vorum, H & Aasbjerg, K 2021, ' Biologic therapy and treatment options in diabetic retinopathy with diabetic macular edema ', Current Drug Safety, vol. 16, no. 1, pp. 17-31 . https://doi.org/10.2174/1574886315666200902154322
Abstract: Proliferative diabetic retinopathy and diabetic macular edema can be a potentially sightthreatening disease if not treated correctly. It is directly correlated to the duration of diabetes and how well managed the patients' diabetes is. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac67c9844367d9e507944385e288fca1
https://doi.org/10.2174/1574886315666200902154322
https://doi.org/10.2174/1574886315666200902154322